image: Official promotional poster for the 6th LabMed Discovery Youth Scholars Salon, including the event theme, speakers, and live broadcast QR code.
Credit: Xue-feng Wang, Hao-ran Feng, Zheng-yang Yang, Xi Cheng
How do we move from biomarkers to clinical decisions in solid tumors? And how is neoadjuvant immunotherapy reshaping rectal cancer care? These are the questions driving our 6th Youth Scholar Salon — an open, live-streamed academic forum held by LabMed Discovery editorial team.
Speaker 1: Dr. Yang will present “Clinical Evidence Accumulation and Standardized Practice of Neoadjuvant Immunotherapy for Rectal Cancer — From Evidence to Guidelines”, from four perspectives: background and challenges, clinical efficacy validation, mechanism exploration, and evidence integration for guidelines.
Speaker 2: Dr. Cheng will share “From Biomarkers to Clinical Decision-Making: Construction of a Predictive System for Targeted Therapy Sensitivity in Solid Tumors”, covering three parts: the research advantages of surgeons, mechanistic insights into anlotinib, preliminary study of anlotinib in CRC application.
Open to all, no prior knowledge needed. Just bring your curiosity. Hope to see you there